Gefitinib API

Holiness Pharmaceutical Ltd is a trusted and leading supplier, exporter of Gefitinib API, supplying high-quality oncology APIs to pharmaceutical companies across 40+ international markets. Gefitinib is an EGFR tyrosine kinase inhibitor widely used in the treatment of non-small cell lung cancer (NSCLC), positioning us as a reliable Gefitinib bulk API supplier from India.

Globally, Holiness Pharmaceutical is recognized among reputable Gefitinib API manufacturers, offering high assay purity, strict impurity control, excellent stability, and consistent batch-to-batch quality suitable for regulated oral oncology formulations. Our expertise in targeted anticancer molecules makes us a dependable Pharmaceutical API exporter.

Our oncology API manufacturing facilities operate in strict compliance with international pharmaceutical regulatory standards including:
➡ DCGI, WHO-GMP, US-FDA aligned, and cGMP guidelines,
ensuring validated synthesis routes, robust impurity profiling, and full pharmacopeial compliance for Gefitinib API.

We export Gefitinib API from India to Asia, Africa, Europe, the Middle East, North America, South America, and CIS regions, supporting formulation manufacturers producing advanced targeted cancer therapies. Holiness Pharmaceutical is widely trusted as a bulk Gefitinib API supplier.

Holiness Pharmaceutical is one of the leading producers of Active Pharmaceutical Ingredients (APIs) and Intermediates, delivering GMP-compliant manufacturing systems, consistent product quality, and globally accepted regulatory documentation as a certified Pharmaceutical API exporter.

Holiness Pharmaceutical Ltd manages the complete lifecycle of API development — including R&D innovation, oncology synthesis, commercial-scale manufacturing, quality assurance, and worldwide API distribution.

Holiness Pharmaceutical has established a strong presence in many countries including:
United States, Canada, United Kingdom, Germany, France, Netherlands, Italy, Spain, Australia, New Zealand, Slovakia, Estonia, Belarus, Ukraine, Iceland, Kazakhstan, Uzbekistan, Turkmenistan, Tajikistan, Kyrgyzstan, Georgia, Russia, Yemen, Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain, Turkey, Senegal, Ethiopia, Eswatini, Cameroon, Zambia, Mozambique, Angola, Zimbabwe, Malawi, Seychelles, South Africa, Nigeria, Kenya, Tanzania, Ghana, Egypt, Panama, Costa Rica, El Salvador, Mexico, Brazil, Argentina, Chile, Peru, Colombia, Afghanistan, Bhutan, Cambodia, Vietnam, Indonesia, Philippines, Malaysia, Thailand, South Korea, Japan, Paraguay, Bangladesh.